137 related articles for article (PubMed ID: 7624143)
1. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.
Nishino H; Knöll A; Buettner VL; Frisk CS; Maruta Y; Haavik J; Sommer SS
Oncogene; 1995 Jul; 11(2):263-70. PubMed ID: 7624143
[TBL] [Abstract][Full Text] [Related]
2. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.
Buettner VL; Hill KA; Nishino H; Schaid DJ; Frisk CS; Sommer SS
Oncogene; 1996 Dec; 13(11):2407-13. PubMed ID: 8957082
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
4. Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice.
Jenks PJ; Jeremy AH; Robinson PA; Walker MM; Crabtree JE
J Pathol; 2003 Dec; 201(4):596-602. PubMed ID: 14648663
[TBL] [Abstract][Full Text] [Related]
5. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous mutation in Big Blue transgenic mice: analysis of age, gender, and tissue type.
Nishino H; Buettner VL; Haavik J; Schaid DJ; Sommer SS
Environ Mol Mutagen; 1996; 28(4):299-312. PubMed ID: 8991057
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice.
de Boer JG; Erfle H; Walsh D; Holcroft J; Provost JS; Rogers B; Tindall KR; Glickman BW
Environ Mol Mutagen; 1997; 30(3):273-86. PubMed ID: 9366905
[TBL] [Abstract][Full Text] [Related]
8. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
[TBL] [Abstract][Full Text] [Related]
9. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: a test of the 'guardian of the genome' hypothesis in the Big Blue transgenic mouse mutation detection system.
Buettner VL; Nishino H; Haavik J; Knöll A; Hill K; Sommer SS
Mutat Res; 1997 Sep; 379(1):13-20. PubMed ID: 9330618
[TBL] [Abstract][Full Text] [Related]
11. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
[TBL] [Abstract][Full Text] [Related]
12. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
[TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
14. HZE particle radiation induces tissue-specific and p53-dependent mutagenesis in transgenic animals.
Chang PY; Kanazawa N; Lutze-Mann L; Winegar R
Phys Med; 2001; 17 Suppl 1():189-91. PubMed ID: 11776257
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
16. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
[TBL] [Abstract][Full Text] [Related]
17. Decreased mutant frequency in embryonic brain of DNA polymerase beta null mice.
Niimi N; Sugo N; Aratani Y; Gondo Y; Katsuki M; Koyama H
Mutagenesis; 2006 Jan; 21(1):55-9. PubMed ID: 16399847
[TBL] [Abstract][Full Text] [Related]
18. Molecular nature of mutations induced by a high dose of x-rays in spleen, liver, and brain of the lacZ-transgenic mouse.
Ono T; Ikehata H; Nakamura S; Saito Y; Komura J; Hosoi Y; Yamamoto K
Environ Mol Mutagen; 1999; 34(2-3):97-105. PubMed ID: 10529732
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectrum in UVB-exposed skin epidermis of Xpa-knockout mice: frequent recovery of triplet mutations.
Ikehata H; Yanase F; Mori T; Nikaido O; Tanaka K; Ono T
Environ Mol Mutagen; 2007 Jan; 48(1):1-13. PubMed ID: 17163503
[TBL] [Abstract][Full Text] [Related]
20. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.
Harvey M; Vogel H; Morris D; Bradley A; Bernstein A; Donehower LA
Nat Genet; 1995 Mar; 9(3):305-11. PubMed ID: 7773294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
